SaxoTV

Buying the biotech boost

215 views
May 06, 2014 amgen, bio tech, bio technology, biogen, biotech, peter garnry, pharma, pharma space, pharmaceutical sales, pharmaceuticals, pharmacies, saxo bank, saxo tv, shares, shares 2014, shares and tapering, shares down, shares drop, shares drops, shares europe, shares or bonds, shares prices, shares up, stock, stock correction, stock decline, stock dividends, stock exchange, stock futures, stock levels, stock market, stock market rally, stock markets, stock options, stock pick, stock picking, stock picks, stock price, stock price increases, stock prices, stock rise, stock sales, stock trading, stock trading 2014, stocks, stocks 2014, stocks markets, stocks to watch, stocks unstoppable, stocks v bonds, stocks”, traders, tradingfloor.com

Leading Bio tech firms, have seen around thirty percent growth in the last year and prospects continue to look good, according to Saxo Bank’s Head of Equity Research, Peter Garnry.   

We’re talking about a futuristic industry, at the leading edge of research, one firm to watch is BioGen Idec Inc (BIIB:xnas), a global biotech company, which has seen around 35 percent growth in its share price over the last year. Shares are now trading around the $290.00 mark. Biogen is well known for developing Multiple Sclerosis  therapies as well as researching drugs for other auto-immune conditions.

The biotech sector has tremendous potential, according to Peter, as the world’s population grows, so will companies exploring the future of drug development.